{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T21:54:31Z","timestamp":1788990871589,"version":"build-2803163510"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>This study evaluates the clinical trends and impact of hepatitis C virus-positive (HCV+) donors on waitlist and posttransplant outcomes after heart transplantation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>The United Network for Organ Sharing registry was queried to identify adult waitlisted and transplanted patients from January 1, 2015, to December 31, 2022. In the waitlist analysis, the candidates were stratified into 2 cohorts based on whether they were willing to accept HCV+ donor offers. Waitlist outcomes included 1-y cumulative incidences of transplantation and death\/delisting. In the posttransplant analysis, the recipients were stratified into 2 cohorts with and without HCV nucleic acid test (NAT)-positive donors. Outcomes included 1- and 4-y posttransplant survival. Propensity score-matching was performed. Risk adjustment was performed using multivariable Cox regression.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>During the study period, the number of centers using HCV NAT+ donors increased from 1 to 65 centers, along with the number of transplants. In the waitlist analysis, 26\u2009648 waitlisted candidates were analyzed, and 4535 candidates (17%) were approved to accept HCV+ donors. Approval to accept HCV+ donors was associated with a higher likelihood of transplantation and a lower likelihood of death\/delisting within 1 y of waitlisting. In the posttransplant analysis, 21\u2009131 recipients were analyzed, and 997 recipients (4.7%) received HCV NAT+ hearts. The 1- and 4-y posttransplant survival were comparable between the recipients of HCV NAT+ and NAT\u2212 donors. Furthermore, the similar 1- and 4-y posttransplant survival persisted in the propensity score-matched comparison and multivariable Cox regression analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>Utilization of HCV+ donors is rising. Heart transplants using HCV+ donors are associated with improved waitlist and comparable posttransplant outcomes.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000005193","type":"journal-article","created":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T20:02:57Z","timestamp":1725480177000},"page":"701-714","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Mid-term Waitlist and Posttransplant Outcomes With Hepatitis C-positive Donor Hearts"],"prefix":"10.1097","volume":"109","author":[{"given":"Yeahwa","family":"Hong","sequence":"first","affiliation":[{"name":"Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA."},{"name":"Department of Cardiothoracic Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin D.","family":"Couper","sequence":"additional","affiliation":[{"name":"Division of Recovery Medicine, Allegheny Health Network, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidhi","family":"Iyanna","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas R.","family":"Hess","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke A.","family":"Ziegler","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Abdullah","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Mathier","sequence":"additional","affiliation":[{"name":"Division of Cardiology, University of Pittsburgh Medical Center, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin W.","family":"Hickey","sequence":"additional","affiliation":[{"name":"Division of Cardiology, University of Pittsburgh Medical Center, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.","family":"Keebler","sequence":"additional","affiliation":[{"name":"Division of Cardiology, University of Pittsburgh Medical Center, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott C.","family":"Silvestry","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Arizona, Tucson, AZ."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kaczorowski","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,9,4]]},"reference":[{"key":"R1-20250325","doi-asserted-by":"crossref","first-page":"a036913","DOI":"10.1101\/cshperspect.a036913","article-title":"Hepatitis C virus epidemiology and the impact of interferon-free hepatitis C virus therapy.","volume":"10","author":"Lazarus","year":"2020","journal-title":"Cold Spring Harb Perspect Med"},{"key":"R2-20250325","first-page":"15","article-title":"The hidden epidemic of hepatitis C virus infection in the United States: occult transmission and burden of disease.","volume":"21","author":"Ward","year":"2013","journal-title":"Top Antivir Med"},{"key":"R3-20250325","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1177\/00333549211047236","article-title":"Testing for hepatitis C virus infection among adults aged \u226518 in the United States, 2013-2017.","volume":"137","author":"King","year":"2022","journal-title":"Public Health Rep"},{"key":"R4-20250325","article-title":"Viral hepatitis surveillance report 2021.","year":"2023"},{"key":"R5-20250325","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.healun.2020.03.004","article-title":"Utilization of hepatitis C virus-infected organ donors in cardiothoracic transplantation: an ISHLT expert consensus statement.","volume":"39","author":"Aslam","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"R6-20250325","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1056\/NEJMc1705221","article-title":"Trial of transplantation of HCV-infected kidneys into uninfected recipients.","volume":"376","author":"Goldberg","year":"2017","journal-title":"N Engl J Med"},{"key":"R7-20250325","doi-asserted-by":"crossref","first-page":"533","DOI":"10.7326\/M17-2871","article-title":"Direct-acting antiviral prophylaxis in kidney transplantation from hepatitis C virus-infected donors to noninfected recipients: an open-label nonrandomized trial.","volume":"168","author":"Durand","year":"2018","journal-title":"Ann Intern Med"},{"key":"R8-20250325","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1002\/hep.30540","article-title":"Increasing utilization and excellent initial outcomes following liver transplant of hepatitis C virus (HCV)-viremic donors into HCV-negative recipients: outcomes following liver transplant of HCV-viremic donors.","volume":"69","author":"Cotter","year":"2019","journal-title":"Hepatology"},{"key":"R9-20250325","doi-asserted-by":"crossref","first-page":"e014495","DOI":"10.1161\/JAHA.119.014495","article-title":"Outcomes of adult heart transplantation using hepatitis C-positive donors.","volume":"9","author":"Kilic","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"R10-20250325","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.healun.2019.06.023","article-title":"Utilization rates and clinical outcomes of hepatitis C positive donor hearts in the contemporary era.","volume":"38","author":"Madan","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"R11-20250325","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/jamacardio.2019.4748","article-title":"Expanding heart transplant in the era of direct-acting antiviral therapy for hepatitis C.","volume":"5","author":"Schlendorf","year":"2020","journal-title":"JAMA Cardiol"},{"key":"R12-20250325","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.healun.2019.08.019","article-title":"Outcomes of heart transplantation from hepatitis C virus-positive donors.","volume":"38","author":"Aslam","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"R13-20250325","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1111\/ajt.15265","article-title":"Variables of importance in the Scientific Registry of Transplant Recipients database predictive of heart transplant waitlist mortality.","volume":"19","author":"Hsich","year":"2019","journal-title":"Am J Transplant"},{"key":"R14-20250325","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.athoracsur.2011.09.037","article-title":"What predicts long-term survival after heart transplantation? An analysis of 9,400 ten-year survivors.","volume":"93","author":"Kilic","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"R15-20250325","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1365-2893.2011.01563.x","article-title":"Economic burden of hepatitis C-associated diseases in the United States.","volume":"19","author":"El Khoury","year":"2012","journal-title":"J Viral Hepat"},{"key":"R16-20250325","doi-asserted-by":"crossref","first-page":"482","DOI":"10.2105\/AJPH.2013.301601","article-title":"Estimating acute viral hepatitis infections from nationally reported cases.","volume":"104","author":"Klevens","year":"2014","journal-title":"Am J Public Health"},{"key":"R17-20250325","doi-asserted-by":"crossref","first-page":"e2245424","DOI":"10.1001\/jamanetworkopen.2022.45424","article-title":"Characteristics and treatment rate of patients with Hepatitis C virus infection in the direct-acting antiviral era and during the COVID-19 pandemic in the United States.","volume":"5","author":"Nguyen","year":"2022","journal-title":"JAMA Netw Open"},{"key":"R18-20250325","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.3748\/wjg.v22.i4.1650","article-title":"Hepatitis C in non-hepatic solid organ transplant candidates and recipients: A new horizon.","volume":"22","author":"Belga","year":"2016","journal-title":"World J Gastroenterol"},{"key":"R19-20250325","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/cid\/ciy585","article-title":"Hepatitis C guidance 2018 update: AASLD-IDSA recommendations for testing, managing, and treating hepatitis C virus infection.","volume":"67","year":"2018","journal-title":"Clin Infect Dis"},{"key":"R20-20250325","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1001\/jama.296.15.1843","article-title":"Hepatitis C virus seropositivity in organ donors and survival in heart transplant recipients.","volume":"296","author":"Gasink","year":"2006","journal-title":"JAMA"},{"key":"R21-20250325","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S1053-2498(00)00062-0","article-title":"Hepatitis C transmission and infection by orthotopic heart transplantation.","volume":"19","author":"Pfau","year":"2000","journal-title":"J Heart Lung Transplant"},{"key":"R22-20250325","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/hep.510300519","article-title":"Outcome of de novo hepatitis C virus infection in heart transplant recipients.","volume":"30","author":"Ong","year":"1999","journal-title":"Hepatology"},{"key":"R23-20250325","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S1053-2498(03)00148-7","article-title":"Donor hepatitis-C seropositivity is an independent risk factor for the development of accelerated coronary vasculopathy and predicts outcome after cardiac transplantation.","volume":"23","author":"Haji","year":"2004","journal-title":"J Heart Lung Transplant"},{"key":"R24-20250325","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1056\/NEJMoa1512610","article-title":"Sofosbuvir and velpatasvir for HCV genotype 1, 2, 4, 5, and 6 infection.","volume":"373","author":"Feld","year":"2015","journal-title":"N Engl J Med"},{"key":"R25-20250325","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1056\/NEJMoa1402454","article-title":"Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection.","volume":"370","author":"Afdhal","year":"2014","journal-title":"N Engl J Med"},{"key":"R26-20250325","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciad319","article-title":"Hepatitis C guidance 2023 update: AASLD-IDSA recommendations for testing, managing, and treating hepatitis C virus infection.","author":"Bhattacharya","year":"2023","journal-title":"Clin Infect Dis"},{"key":"R27-20250325","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s40472-021-00350-1","article-title":"Hepatitis C positive organ donation in heart transplantation.","volume":"8","author":"Siddiqi","year":"2021","journal-title":"Curr Transplant Rep"},{"key":"R28-20250325","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1056\/NEJMoa1812406","article-title":"Heart and lung transplants from HCV-Infected donors to uninfected recipients.","volume":"380","author":"Woolley","year":"2019","journal-title":"N Engl J Med"},{"key":"R29-20250325","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.healun.2018.01.1293","article-title":"Early outcomes using hepatitis C-positive donors for cardiac transplantation in the era of effective direct-acting anti-viral therapies.","volume":"37","author":"Schlendorf","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"R30-20250325","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S2468-1253(19)30240-7","article-title":"Pre-emptive pangenotypic direct acting antiviral therapy in donor HCV-positive to recipient HCV-negative heart transplantation: an open-label study.","volume":"4","author":"Bethea","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R31-20250325","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.healun.2020.06.022","article-title":"Increased early acute cellular rejection events in hepatitis C-positive heart transplantation.","volume":"39","author":"Gidea","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"R32-20250325","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/hrt.2003.018937","article-title":"Evidence for association between hepatitis C virus seropositivity and coronary artery disease.","volume":"90","author":"Vassalle","year":"2004","journal-title":"Heart"},{"key":"R33-20250325","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0140-6736(02)07339-7","article-title":"Association between hepatitis C virus seropositivity, carotid-artery plaque, and intima-media thickening.","volume":"359","author":"Ishizaka","year":"2002","journal-title":"Lancet"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005193","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T07:28:35Z","timestamp":1743146915000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,4]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000005193","relation":{},"ISSN":["0041-1337","1534-6080"],"issn-type":[{"value":"0041-1337","type":"print"},{"value":"1534-6080","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,4]]}}}